Anika Therapeutics, Inc. (ANIK) — 10-K/A Filings

All 10-K/A filings from Anika Therapeutics, Inc.. Browse 1 Amended Annual Report reports with AI-powered summaries and risk analysis.

10-K/A Filings (1)

  • Anika Therapeutics Files 10-K/A Amendment — Apr 26, 2024 Risk: low
    Anika Therapeutics, Inc. (ANIK) filed a Amended Annual Report (10-K/A) with the SEC on April 26, 2024. Anika Therapeutics, Inc. filed an amendment (10-K/A) to i

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.